Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
6
×
boston blog main
6
×
life sciences
6
×
national blog main
clinical trials
san francisco blog main
boston top stories
san francisco top stories
abbvie
fda
raleigh-durham blog main
boston
cancer
cancer diagnostics
freenome
grail
indiana blog main
investing
johnson & johnson
liquid biopsy
medical device
multiple myeloma
national
national top stories
new york blog main
non-hodgkin lymphoma
novartis
novo nordisk
pfizer
raleigh-durham top stories
roche
san diego blog main
san francisco
seattle blog main
software
startups
thrive earlier detection
venture capital
#ash2018
2018
What
blood
6
×
developing
medical
tests
cancer
company
diabetes
intended
levels
medicine
sugar
treatments
advance
american
anemia
announced
annual
area
ash
available
balance
based
bay
beta
biome
bionics
biopsy
body
borne
broader
buildout
cancers
carry
cells
close
closed
conference
detect
device
diego
Language
unset
Current search:
blood
×
biotech
×
" life sciences "
×
" boston blog main "
×
@xconomy.com
3 years ago
Grail Files to Go Public; 5 More Life Science Firms Join the IPO Queue
@xconomy.com
4 years ago
Liquid Biopsy Firm Lucence Plans Bay Area Buildout With $20M in Tow
@xconomy.com
4 years ago
Disc Medicine Launches With $50M to Advance New Anemia Treatments
@xconomy.com
4 years ago
With $35M, Whole Biome Eyes 2020 Launch of Medical Food for Diabetes
@xconomy.com
5 years ago
Beta Bionics Secures $63M as AI-Driven “Pancreas” Heads to Key Tests
@xconomy.com
5 years ago
ASH 2018: A Guide to the Latest for Blood-Borne Cancers and More